BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1355 related articles for article (PubMed ID: 17540599)

  • 1. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis.
    Chang TC; Wentzel EA; Kent OA; Ramachandran K; Mullendore M; Lee KH; Feldmann G; Yamakuchi M; Ferlito M; Lowenstein CJ; Arking DE; Beer MA; Maitra A; Mendell JT
    Mol Cell; 2007 Jun; 26(5):745-52. PubMed ID: 17540599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network.
    Samuel N; Wilson G; Id Said B; Pan A; Deblois G; Fischer NW; Alexandrova R; Casallo G; Paton T; Lupien M; Gariepy J; Merico D; Hudson TJ; Malkin D
    Oncotarget; 2016 Aug; 7(31):49611-49622. PubMed ID: 27391063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Temperature Sensitive Variant of p53 Drives p53-Dependent MicroRNA Expression without Evidence of Widespread Post-Transcriptional Gene Silencing.
    Cabrita MA; Vanzyl EJ; Hamill JD; Pan E; Marcellus KA; Tolls VJ; Alonzi RC; Pastic A; Rambo TM; Sayed H; McKay BC
    PLoS One; 2016; 11(2):e0148529. PubMed ID: 26840126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of miR-34a in p53 deficient cells unexpectedly promotes the cell survival by increasing NFκB activity.
    Tan J; Fan L; Mao JJ; Chen B; Zheng L; Zhang T; Li T; Duan J; Duan Y; Jin Z; Kuang W
    J Cell Biochem; 2012 Sep; 113(9):2903-8. PubMed ID: 22531959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of p53/miR-34a regulatory axis decreases survival advantage and ensures Bax-dependent apoptosis of non-small cell lung carcinoma cells.
    Chakraborty S; Mazumdar M; Mukherjee S; Bhattacharjee P; Adhikary A; Manna A; Chakraborty S; Khan P; Sen A; Das T
    FEBS Lett; 2014 Feb; 588(4):549-59. PubMed ID: 24444609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest.
    Tarasov V; Jung P; Verdoodt B; Lodygin D; Epanchintsev A; Menssen A; Meister G; Hermeking H
    Cell Cycle; 2007 Jul; 6(13):1586-93. PubMed ID: 17554199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of miR-34a-5p antagonizes AFB1-induced genotoxicity in F344 rat liver.
    Liu C; Yu H; Zhang Y; Li D; Xing X; Chen L; Zeng X; Xu D; Fan Q; Xiao Y; Chen W; Wang Q
    Toxicon; 2015 Nov; 106():46-56. PubMed ID: 26385312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-150, p53 protein and relevant miRNAs consist of a regulatory network in NSCLC tumorigenesis.
    Wang DT; Ma ZL; Li YL; Wang YQ; Zhao BT; Wei JL; Qi X; Zhao XT; Jin YX
    Oncol Rep; 2013 Jul; 30(1):492-8. PubMed ID: 23670238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression level of miR-34a rather than P53 gene status correlates with mutability in related human lymphoblast cell lines.
    Chen X; Yan J; Chen T
    Mol Carcinog; 2012 Aug; 51(8):674-7. PubMed ID: 21809390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.
    Castro RE; Ferreira DM; Afonso MB; Borralho PM; Machado MV; Cortez-Pinto H; Rodrigues CM
    J Hepatol; 2013 Jan; 58(1):119-25. PubMed ID: 22902550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
    Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
    Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-23a binds to p53 and enhances its association with miR-128 promoter.
    Li J; Aung LH; Long B; Qin D; An S; Li P
    Sci Rep; 2015 Nov; 5():16422. PubMed ID: 26553132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation.
    Rizzo M; Mariani L; Cavallini S; Simili M; Rainaldi G
    Nucleic Acid Ther; 2012 Aug; 22(4):283-8. PubMed ID: 22830357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34 and p53: New Insights into a Complex Functional Relationship.
    Navarro F; Lieberman J
    PLoS One; 2015; 10(7):e0132767. PubMed ID: 26177460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A microRNA component of the p53 tumour suppressor network.
    He L; He X; Lim LP; de Stanchina E; Xuan Z; Liang Y; Xue W; Zender L; Magnus J; Ridzon D; Jackson AL; Linsley PS; Chen C; Lowe SW; Cleary MA; Hannon GJ
    Nature; 2007 Jun; 447(7148):1130-4. PubMed ID: 17554337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.